Organogenesis Holdings (ORGO) Operating Income Growth (5y) (2021 - 2026)
Organogenesis Holdings (ORGO) Operating Income Growth (5y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.55 Bn | 87.69 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn |
| 3 | Zoetis | 32.71 Bn | 30.77 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.65 Bn | 23.59 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.18 Bn | 21.03 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.30 Bn | 18.50 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.84 Bn | 16.52 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Organogenesis Holdings | 322.69 Mn | 230.59 Mn | 11.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.47% |
| Dec 31, 2025 | 24.00% |
| Sep 30, 2025 | -1.89% |
| Jun 30, 2025 | -41.06% |
| Mar 31, 2025 | -12.14% |
| Dec 31, 2024 | 46.53% |
| Sep 30, 2024 | 22.47% |
| Jun 30, 2024 | -13.67% |
| Mar 31, 2024 | 20.49% |
| Dec 31, 2023 | 22.30% |
| Sep 30, 2023 | 22.86% |
| Jun 30, 2023 | 20.80% |
| Mar 31, 2023 | 27.50% |
| Dec 31, 2022 | 41.28% |
| Sep 30, 2022 | 21.79% |
| Jun 30, 2022 | 36.76% |
| Mar 31, 2022 | 46.68% |
| Dec 31, 2021 | 76.67% |
| Sep 30, 2021 | 307.54% |
| Mar 31, 2021 | 281.99% |